The Protocol of Circulating Tumor Cell Detection
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
The detection of CTCs is related to the development of tumors and can be used in medical fields such as early diagnosis, postoperative evaluation, monitoring treatment, and predicting disease prognosis. This article focuses on the entire process of CTC detection, including negative enrichment isolation and immunofluorescence in situ hybridization detection.
References
1.
Lin J, Zheng J, Wu A
. An efficient strategy for circulating tumor cell detection: surface-enhanced Raman spectroscopy. J Mater Chem B. 2019; 8(16):3316-3326.
DOI: 10.1039/c9tb02327e.
View
2.
Zhang J, Chen K, Fan Z
. Circulating Tumor Cell Isolation and Analysis. Adv Clin Chem. 2016; 75:1-31.
PMC: 5123699.
DOI: 10.1016/bs.acc.2016.03.003.
View
3.
Ferreira M, Ramani V, Jeffrey S
. Circulating tumor cell technologies. Mol Oncol. 2016; 10(3):374-94.
PMC: 5528969.
DOI: 10.1016/j.molonc.2016.01.007.
View
4.
Sun Y, Yang X, Zhou J, Qiu S, Fan J, Xu Y
. Circulating tumor cells: advances in detection methods, biological issues, and clinical relevance. J Cancer Res Clin Oncol. 2011; 137(8):1151-73.
DOI: 10.1007/s00432-011-0988-y.
View
5.
Sharma S, Zhuang R, Long M, Pavlovic M, Kang Y, Ilyas A
. Circulating tumor cell isolation, culture, and downstream molecular analysis. Biotechnol Adv. 2018; 36(4):1063-1078.
PMC: 5971144.
DOI: 10.1016/j.biotechadv.2018.03.007.
View